Danstan Bagenda
University of Nebraska Medical Center
70 Papers
469 Citations
Danstan Bagenda is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 25, co-authored 61 publications. Previous affiliations of Danstan Bagenda include College of Health Sciences, Bahrain & Johns Hopkins University.
Chat about Author
Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
Laura Guay,Philippa Musoke,Thomas Fleming,Danstan Bagenda,Melissa Allen,Clemensia Nakabiito,Joseph Sherman,Paul M Bakaki,Constance Ducar,Martina Deseyve,Lynda Emel,Mark Mirochnick,Mary Glenn Fowler,Lynne M. Mofenson,Paolo G. Miotti,Kevin Dransfield,Dorothy Bray,Francis Mmiro,J. Brooks Jackson +18 more
TL;DR: Nevirapine lowered the risk of HIV-1 transmission during the first 14-16 weeks of life by nearly 50% in a breastfeeding population, suggesting this simple and inexpensive regimen could decrease mother-to-child HIV- 1 transmission in less-developed countries.
1.8K
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow up of the HIVNET 012 randomized trial
J. Brooks Jackson,Philippa Musoke,Tom P. Fleming,Laura Guay,Danstan Bagenda,Melissa Allen,Clemensia Nakabiito,Joseph Sherman,Paul M. Bakaki,Maxensia Owor,Contance Ducar,Martina Deseyve,Anthony Mwatha,Lynda Emel,Corey Duefield,Mark Mirochnick,Mary Glenn Fowler,Lynne M. Mofenson,Paolo G. Miotti,Maria Gigllottl,Dorothy Bray,Francis Mmiro +21 more
TL;DR: Intrapartum/neonatal nevirapine appears to be a simple, inexpensive, and well-tolerated regimen for significantly reducing perinatal transmission of HIV-1 in less developed countries.
426
Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries.
Kristina E. Rudd,Christopher W. Seymour,Adam R. Aluisio,Marc E. Augustin,Danstan Bagenda,Abi Beane,Abi Beane,Jean Claude Byiringiro,Chung-Chou H. Chang,L. Nathalie Colas,Nicholas P. J. Day,Nicholas P. J. Day,A. Pubudu De Silva,Arjen M. Dondorp,Arjen M. Dondorp,Martin W. Dünser,M. Abul Faiz,Donald S. Grant,Rashan Haniffa,Nguyen Van Hao,Jason Kennedy,Adam C. Levine,Direk Limmathurotsakul,Direk Limmathurotsakul,Sanjib Mohanty,François Nosten,François Nosten,Alfred Papali,Andrew J. Patterson,John S. Schieffelin,Jeffrey G. Shaffer,Duong Bich Thuy,C. Louise Thwaites,Olivier Urayeneza,Nicholas J. White,Nicholas J. White,T. Eoin West,Derek C. Angus +37 more
TL;DR: When assessed among hospitalized adults with suspected infection in 9 LMIC cohorts, the qSOFA score identified infected patients at risk of death beyond that explained by baseline factors, however, the predictive validity varied among cohorts and settings, and further research is needed to better understand potential generalizability.
Patterns and Predictors of Self-Medication in Northern Uganda
Moses Ocan,Freddie Bwanga,Godfrey S. Bbosa,Danstan Bagenda,Paul Waako,Jasper Ogwal-Okeng,Celestino Obua +6 more
TL;DR: Predictors of self-medication with antimicrobial agents included gender, drug knowledge, drug leaflets, advice from friends, previous experience, long waiting time, and distance to the health facility.
Growth Failure as a Prognostic Indicator of Mortality in Pediatric HIV Infection
Rahel Berhane,Danstan Bagenda,Lawrence H. Marum,Esther Aceng,Christopher M. Ndugwa,Ronald J Bosch,Karen Olness +6 more
TL;DR: Perinatally acquired HIV infection is associated with early and progressive growth failure, and the severity of growth failure isassociated with an increased risk of mortality.
141